Catalio Capital Management’s Outset Medical OM Stock Holding History

Catalio Capital Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$511K	Hold	118,279	–	–	0.1%	38
2026 Q1	$454K	Hold	118,279	–	–	0.09%	41
2025 Q4	$439K	Hold	118,279	–	–	0.08%	44
2025 Q3	$1.67M	Sell	118,279 -48,387	-29%	-$754K	0.31%	31
2025 Q2	$3.2M	Hold	166,666	–	–	0.67%	25
2025 Q1	$1.84M	Buy	+166,666	New	+$1.99M	0.45%	27

Other funds holding OM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Catalio Capital Management's OM Position: Q2 2026 in Review

Catalio Capital Management held its Outset Medical (OM) position steady in Q2 2026 at 118,279 shares worth $511K. The position accounts for 0.1% of the portfolio, ranked #38.

Catalio Capital Management first reported a position in OM in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.2M in Q2 2025. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

Catalio Capital Management held 118,279 shares of Outset Medical worth $511K as of Q2 2026.
Catalio Capital Management left its Outset Medical share count unchanged in Q2 2026.
Outset Medical made up 0.1% of Catalio Capital Management's portfolio in Q2 2026, its #38 holding.
Catalio Capital Management first reported a position in Outset Medical in Q1 2025 and has held it in 6 quarters since.
Catalio Capital Management's Outset Medical position peaked at $3.2M in Q2 2025.
93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Catalio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.